Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Transplantation in Children and Young Adults With Hematologic Malignancies
NCT07566377Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2026
- Primary completion
- Apr 2030
- Countries
- 1
01
Overview
Phase 2, open-label trial in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and 2 more (2 cohorts), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Disease-free Survival at 1 year. Started Apr 2026; status: recruiting.
02
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT07566377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07566377.